GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating ...
Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...
Learn how new brain scans link long COVID to changes in the dopamine system that may help explain fatigue, brain fog, and ...